Contact us today for a complimentary consultation with a qualified attorney near you.
-April 19, 2004
After a letter said an analysis of safety databases indicate some Accolate patients experienced liver problems, including hepatitis, shares in Accolate's AstraZeneca Plc slipped. While Accolate labels do warn of potential liver problems already, it is important for all consumers to be aware of drug risks as well as potential benefits. For more information on Accolate, please contact us.